Frontlight ResearchEarly access
Trial site
Minnesota Oncology Hematology, P.A.
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Metastatic breast cancer4 trials
- Cervical cancer2 trials
- Endometrial cancer2 trials
- Gastric and oesophageal cancer2 trials
- Head and neck cancer2 trials
- Ovarian cancer2 trials
- Bladder cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- and 2 more
- Phase
- Phase 37 trials
- Phase 25 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Recruiting4 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Pfizer3 trials
- US Oncology Research3 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Bristol-Myers Squibb1 trial
- Daiichi Sankyo1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
- Endometrial cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026